Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Report

Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report By Source, By Service (Upstream, Downstream, Fill/Finish), By Product (Biologics), By Region And Segment Forecasts, 2022 - 2030

Report ID: GVR-2-68038-698-1
Number of Pages: 193
Format: Electronic (PDF)

Historical Range: 2017 - 2020
Industry: Healthcare

Market Segmentation

Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2017 - 2030)
- Mammalian
- Non-mammalian
Biopharmaceuticals Contract Manufacturin, Service Outlook (Revenue, USD Million, 2017 - 2030)
- Process Development
  - Downstream
  - Upstream
- Fill & Finish Operations
- Analytical & QC studies
- Packaging
Biopharmaceuticals Contract Manufacturing Product Outlook (Revenue, USD Million, 2017 - 2030)
- Biologics
  - Monoclonal antibodies (MABs)
  - Recombinant Proteins
  - Vaccines
  - Antisense, RNAi, & Molecular Therapy
  - Others
- BiosimilarsOthers
Biopharmaceuticals Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2017 - 2030)
- Oncology
- Autoimmune Diseases
- Metabolic Diseases
- Cardiovascular Diseases
- Neurology
- Infectious Diseases
- Others
Biopharmaceuticals Contract Manufacturing Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
  - North America Biopharmaceuticals Contract Manufacturing Market, By Source
    - Mammalian
    - Non-mammalian
  - North America Biopharmaceuticals Contract Manufacturing Market, By Service
    - Process Development
      - Downstream
      - Upstream
    - Fill & Finish Operations
    - Analytical & QC studies
    - Packaging
  - North America Biopharmaceuticals contract manufacturing Market, by Product
    - Biologics
      - Monoclonal antibodies (MABs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - North America Biopharmaceuticals contract manufacturing Market, by Product
    - Oncology
    - Autoimmune Diseases
    - Metabolic Diseases
    - Cardiovascular Diseases
    - Neurology
    - Infectious Diseases
    - Others
  - U.S.
    - U.S. Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - U.S. Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - U.S. Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - U.S. Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
  - Canada
    - Canada Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - Canada Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Canada Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - Canada Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
- Europe
  - Europe Biopharmaceuticals Contract Manufacturing Market, By Source
    - Mammalian
    - Non-mammalian
  - Europe Biopharmaceuticals Contract Manufacturing Market, By Service
    - Process Development
      - Downstream
      - Upstream
    - Fill & Finish Operations
    - Analytical & QC studies
    - Packaging
  - Europe Biopharmaceuticals contract manufacturing Market, by Product
    - Biologics
      - Monoclonal antibodies (MABs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - Europe Biopharmaceuticals contract manufacturing Market, by Product
    - Oncology
    - Autoimmune Diseases
    - Metabolic Diseases
    - Cardiovascular Diseases
    - Neurology
    - Infectious Diseases
    - Others
  - UK
    - U.K Biopharmaceuticals Contract Manufacturing Market, By Source
      - Mammalian
      - Non-mammalian
    - U.K Biopharmaceuticals Contract Manufacturing Market, By Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - U.K Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - U.K Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
  - Germany
    - Germany Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - Germany Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Germany Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - Germany Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
  - France
    - France Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - France Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - France Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - France Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
    - Italy
    - Spain
      - Spain Biopharmaceuticals Contract Manufacturing Market, by Source
        
        Mammalian
        
        Non-mammalian
      - Spain Biopharmaceuticals Contract Manufacturing Market, by Service
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Spain Biopharmaceuticals contract manufacturing Market, by Product
        
        Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
        
        Biosimilars
      - Spain Biopharmaceuticals contract manufacturing Market, by Product
        
        Oncology
        
        Autoimmune Diseases
        
        Metabolic Diseases
        
        Cardiovascular Diseases
        
        Neurology
        
        Infectious Diseases
        
        Others
- Asia Pacific
  - Asia Pacific Biopharmaceuticals Contract Manufacturing Market, By Source
    - Mammalian
    - Non-mammalian
  - Asia Pacific Biopharmaceuticals Contract Manufacturing Market, By Service
    - Process Development
      - Downstream
      - Upstream
    - Fill & Finish Operations
    - Analytical & QC studies
    - Packaging
  - Asia Pacific Biopharmaceuticals contract manufacturing Market, by Product
    - Biologics
      - Monoclonal antibodies (MABs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - Asia Pacific Biopharmaceuticals contract manufacturing Market, by Product
    - Oncology
    - Autoimmune Diseases
    - Metabolic Diseases
    - Cardiovascular Diseases
    - Neurology
    - Infectious Diseases
    - Others
  - China
    - China Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - China Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - China Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - China Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
  - India
    - India Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - India Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - India Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - India Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
      - Japan
  - Australia
    - Australia Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - Australia Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Australia Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - Australia Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
      - Japan
  - South Korea
    - South Korea Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - South Korea Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - South Korea Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - South Korea Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
      - Japan
- Latin America
  - Latin America Biopharmaceuticals Contract Manufacturing Market, By Source
    - Mammalian
    - Non-mammalian
  - Latin America Biopharmaceuticals Contract Manufacturing Market, By Service
    - Process Development
      - Downstream
      - Upstream
    - Fill & Finish Operations
    - Analytical & QC studies
    - Packaging
  - Latin America Biopharmaceuticals contract manufacturing Market, by Product
    - Biologics
      - Monoclonal antibodies (MABs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - Latin America Biopharmaceuticals contract manufacturing Market, by Product
    - Oncology
    - Autoimmune Diseases
    - Metabolic Diseases
    - Cardiovascular Diseases
    - Neurology
    - Infectious Diseases
    - Others
  - Brazil
    - Brazil Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - Brazil Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Brazil Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - Brazil Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
      - Colombia
  - Mexico
    - Mexico Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - Mexico Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Mexico Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - Mexico Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
      - Colombia
  - Argentina
    - Argentina Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - Argentina Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Argentina Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - Argentina Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
      - Colombia
- Middle East & Africa (MEA)
  - MEA Biopharmaceuticals Contract Manufacturing Market, By Source
    - Mammalian
    - Non-mammalian
  - MEA Biopharmaceuticals Contract Manufacturing Market, By Service
    - Process Development
      - Downstream
      - Upstream
    - Fill & Finish Operations
    - Analytical & QC studies
    - Packaging
  - MEA Biopharmaceuticals contract manufacturing Market, by Product
    - Biologics
      - Monoclonal antibodies (MABs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - MEA Biopharmaceuticals contract manufacturing Market, by Product
    - Oncology
    - Autoimmune Diseases
    - Metabolic Diseases
    - Cardiovascular Diseases
    - Neurology
    - Infectious Diseases
    - Others
  - South Africa
    - South Africa Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - South Africa Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - South Africa Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - South Africa Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
  - Saudi Arabia
    - Saudi Arabia Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - Saudi Arabia Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Saudi Arabia Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - Saudi Arabia Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others
  - UAE
    - UAE Biopharmaceuticals Contract Manufacturing Market, by Source
      - Mammalian
      - Non-mammalian
    - UAE Biopharmaceuticals Contract Manufacturing Market, by Service
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - UAE Biopharmaceuticals contract manufacturing Market, by Product
      - Biologics
        
        Monoclonal antibodies (MABs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
    - UAE Biopharmaceuticals contract manufacturing Market, by Product
      - Oncology
      - Autoimmune Diseases
      - Metabolic Diseases
      - Cardiovascular Diseases
      - Neurology
      - Infectious Diseases
      - Others

Biopharmaceuticals Contract Manufacturing Market Dynamics

Driver: Commercial success of biopharmaceuticals and consequent increase in the demand for biopharmaceuticals

The biopharmaceutical manufacturing sector is widely acknowledged as a prominent industry with immense growth potential. Many healthcare organizations predict that this sector will be among the top 10 revenue generators in the coming years. Market players are actively working towards developing this sector to meet the rising demand for bio-based pharmaceuticals, which is expected to impact biopharmaceutical production positively. This robust growth has led to the emergence of a substantial product pipeline. In 2019, the FDA approved 36 biopharmaceutical products, including recombinant proteins and monoclonal antibodies. The biopharmaceutical R&D segment is also projected to experience growth in the upcoming years. According to the International Federation of Pharmaceutical Manufacturers & Associations, pharmaceutical R&D spending reached USD 179 million in 2018 and is anticipated to reach USD 213 million by 2025. The increase in pharmaceutical R&D is expected to drive the growth of the biopharmaceutical R&D segment due to the high demand for biopharmaceuticals. The number of drugs in the pipeline has significantly risen in recent years. In 2018 and 2021, there were 15,267 and 18,582 drugs in the pipeline, respectively, according to Pharma Intelligence. This surge in the number of drugs in the pipeline is expected to propel the market forward. The biologics industry has achieved tremendous success thanks to rapid advancements in bioprocessing engineering and the gradual evolution of contract services. The rate of FDA approval for biotechnology products, including antibodies, coagulation proteins, fusion proteins, growth factors, interferons, liposomes, vaccines, cell/tissue therapies, enzymes, hormones, interleukins, peptides, and others, is observed to be approximately 12 products per year in the U.S.

Driver: Robust biopharmaceuticals pipeline contributing to the demand for outsourcing

The rapid increase in the number of biopharmaceuticals is driving the market growth. This increase has also led to a higher demand for outsourcing services to reduce the time it takes to bring these products to market. Smaller and larger firms see outsourcing as a cost-effective way to improve their product pipeline and increase their presence in the biopharmaceutical market. As a result, the adoption of these services is expected to increase in the coming years due to a strong pipeline and a lack of sufficient capacity. Additionally, the market is expected to see a significant number of biosimilars entering in the next few years, including several blockbuster monoclonal antibodies. This is likely to impact the adoption of contract services positively.

Restraint: Unintended effects of biopharmaceuticals on the immune function that lead to infections

The use of biopharmaceuticals has brought about a revolution in the management of several chronic diseases. However, it has been observed that these therapeutics can have unintended consequences on the immune function, resulting in severe infections. Patients receiving biopharmaceutical drugs that inhibit specific immune system functions are at an increased risk of opportunistic infections. This factor may negatively impact the adoption rate of biopharmaceuticals and subsequently affect revenue generation. Biopharmaceuticals that pose a risk of infectious diseases include monoclonal antibodies, T & B cells, antithymocyte globulin, agents that disrupt T-cell co-stimulation signals, and anticytokine therapies. Additionally, biologic response modifiers have been found to increase the likelihood of certain severe and opportunistic infections, particularly mycobacterial and viral infections. Furthermore, biopharmaceuticals can also have various other side effects, such as difficulty in breathing, severe allergic reactions, chest pain or tightness, fever or chills, swelling of the face and hands, and high or low blood pressure. These unintended effects of biopharmaceuticals may hinder market growth.

What Does This Report Include?

This section will provide insights into the contents included in this biopharmaceuticals contract manufacturing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Biopharmaceuticals contract manufacturing market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Biopharmaceuticals contract manufacturing market quantitative analysis

Market size, estimates, and forecast from 2017 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.